RecruitingNot Applicable

Hemodynamic ABI Monitor

United States50 participantsStarted 2024-12-06

Plain-language summary

The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data. Participants already taking intervention A as part of their regular medical care and the investigators will follow up with participants 6 months after discharging the hospital.

Who can participate

Age range

18 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion: Patients who are: * Admitted to the University of Chicago Medical Center Neurocritical Care Unit * Adults between 18 years and 80 * Admitted with Traumatic brain injury blunt and penetrating or nontraumatic intracerebral hemorrhage * post-resuscitation Glasgow Coma Scale (GCS) \<9 Exclusion: Patients who were: * Pre-existing heart failure * Moribund or neurological exam suggesting imminent brain death (bilateral, fixed and dilated pupils) on admission * Major polytrauma or admitted to the surgical trauma critical care service * Prisoner

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

functional outcomes

Timeframe: 180 days after discharging the hospital

Trial details

NCT IDNCT06725108

SponsorUniversity of Chicago

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-06

Contact for this trial

Farima Fakhri, MD

3126102482 farima.fakhri@bsd.uchicago.edu

View on ClinicalTrials.gov More Traumatic Brain Injury (TBI) trials